CD40在潰瘍性結(jié)腸炎發(fā)病機(jī)制中作用的實(shí)驗(yàn)研究
本文選題:CD40 + 潰瘍性結(jié)腸炎。 參考:《蘇州大學(xué)》2014年博士論文
【摘要】:第一部分CD40在潰瘍性結(jié)腸炎組織中的表達(dá)及意義 目的:研究CD40分子在潰瘍性結(jié)腸炎組織中的表達(dá),及其與潰瘍性結(jié)腸炎嚴(yán)重度之間的相關(guān)性。 方法:應(yīng)用免疫組化技術(shù)檢測(cè)56例潰瘍性結(jié)腸炎組織和10例正常組織中CD40分子表達(dá)。 結(jié)果:CD40分子在潰瘍性結(jié)腸炎組織中的陽(yáng)性表達(dá)率為62.5%,明顯高于對(duì)照組(P<0.05)。與輕度潰瘍性結(jié)腸炎相比,CD40陽(yáng)性表達(dá)率在中度潰瘍性結(jié)腸炎中明顯升高(P<0.05)。 結(jié)論:潰瘍性結(jié)腸炎患者結(jié)腸組織中CD40表達(dá)異常。 第二部分抗CD40單克隆抗體在潰瘍性結(jié)腸炎中治療效應(yīng)及作用機(jī)制的 實(shí)驗(yàn)研究 目的初步探討抗CD40單克隆抗體在葡聚糖硫酸鈉(dextran sulfate sodium, DSS)誘導(dǎo)的小鼠潰瘍性結(jié)腸炎(ulcerative colitis, UC)中的治療效應(yīng)及作用機(jī)制。方法24只BALB/c小鼠按隨機(jī)數(shù)字表分為:A組(對(duì)照組,n=6)、B組(模型組,n=6)、C組(奧沙拉秦干預(yù)組,n=6)、D組(抗CD40單克隆抗體干預(yù)組,n=6)。A組小鼠自由飲用蒸餾水7天;B、C、D組小鼠自由飲用5%DSS溶液7天以制成UC小鼠模型;造模的同時(shí)于第1、3、5及7天分別給以A、B組腹腔注射無(wú)菌蒸餾水。C組小鼠每天灌服奧沙拉秦(60mg/kg)、D組小鼠于造模第1、3、5、7天腹腔注射抗CD40單克隆抗體(20ug/次),,于造模第8天,處死所有各組小鼠。大體觀察各組小鼠疾病活動(dòng)指數(shù)(disease activity index, DAI),常規(guī)病理切片評(píng)估結(jié)腸組織病理學(xué)評(píng)分(histopathological score, HPS)。RT-PCR測(cè)定各組小鼠遠(yuǎn)端結(jié)腸中IFN-γmRNA、TNF-αmRNA的表達(dá),ELISA法測(cè)定各組小鼠血清中IFN-γ、TNF-α含量的變化。 結(jié)果(1)與對(duì)照組DAI(0.29±0.48)和HPS(0.16±0.32)相比,模型組小鼠DAI(6.21±1.25)和HPS(7.00±0.58)明顯增高(p0.05);與模型組相比,奧沙拉秦干預(yù)組C組DAI(4.58±2.36)和HPS(4.35±0.76)均有不同程度的下降(p0.05);抗CD40單克隆抗體干預(yù)組D組DAI(3.98±1.86)和HPS(3.25±0.66)亦有不同程度的下降(p0.05)(2)模型組IFN-γ mRNA、TNF-mRNA表達(dá)量(分別為3.21±0.26、1.23±0.36)明顯高于對(duì)照組(分別為1.35±0.18、0.21±0.13)(p0.05),奧沙拉秦干預(yù)后,IFN-γ mRNA、TNF-mRNA表達(dá)在C組(2.58±0.24、0.72±0.15)、抗CD40單克隆抗體干預(yù)組D組(2.34±0.25、0.59±0.18)均顯著下降(p0.05)。(3)對(duì)照組小鼠血清中IFN-γ、TNF-α的水平分別為(215.18±32.51)、(20.06±5.20),模型組小鼠血清中IFN-γ、TNF-α的表達(dá)比例分別為(953.32±40.96)、(42.97±8.76),模型組小鼠血清中IFN-γ、TNF-α的表達(dá)比例與對(duì)照組相比明顯升高(P0.05),奧沙拉秦干預(yù)后C組、抗CD40抗體干預(yù)組D組小鼠血清中IFN-γ、TNF-α的表達(dá)比例分別為C組(768.73±31.86)、(37.75±6.75)、D組(693.47±51.38)、(30.93±3.18),與模型組相比干預(yù)組均有明顯降低(P0.05); 結(jié)論(1)抗CD40抗體干預(yù)組干預(yù)的UC小鼠模型大體癥狀可明顯好轉(zhuǎn),結(jié)腸炎癥程度亦得到明顯減輕;(2)奧沙拉秦干預(yù)后C組、抗CD40抗體干預(yù)組D組的UC小鼠遠(yuǎn)端結(jié)腸中IFN-γ mRNA、TNF-αmRNA明顯下降,提示促炎性細(xì)胞因子在UC發(fā)病中可能發(fā)揮重要作用;(3)抗CD40抗體干預(yù)的UC小鼠血清中IFN-γ和TNF-α的表達(dá)水平均明顯下降;提示抗CD40單克隆抗體可下調(diào)效應(yīng)細(xì)胞因子,減輕UC炎癥。
[Abstract]:Expression and significance of first part CD40 in ulcerative colitis
Objective : To study the expression of CD40 molecule in ulcerative colitis and its correlation with the severity of ulcerative colitis .
Methods : Immunohistochemical technique was used to detect the expression of CD40 in 56 ulcerative colitis and 10 normal tissues .
Results : The positive expression rate of CD40 molecule in ulcerative colitis was 62.5 % , which was significantly higher than that in control group ( P < 0.05 ) .
Conclusion : The expression of CD40 in colonic tissues of patients with ulcerative colitis is abnormal .
Effect of the second part of anti - CD40 monoclonal antibody on ulcerative colitis and its mechanism of action
experimental study
Objective To investigate the therapeutic effect and mechanism of anti - CD40 monoclonal antibody in ulcerative colitis ( UC ) induced by dextran sulfate sodium ( DSS ) . Methods Twenty - four BALB / c mice were randomly divided into group A ( control group , n = 6 ) , group B ( model group , n = 6 ) , group C ( group C , n = 6 ) and D group ( anti - CD40 monoclonal antibody intervention group , n = 6 ) . Group A mice were free to drink distilled water for 7 days ;
B , C and D groups were free to drink 5 % DSS solution for 7 days to prepare UC mice model ;
All groups of mice were sacrificed on Days 1 , 3 , 5 and 7 , respectively , and the mice were given intraperitoneal injection of the anti - CD40 monoclonal antibody ( 20ug / kg ) on day 1 , 3 , 5 and 7 . All the groups of mice were sacrificed on the 8th day of the molding . The disease activity index ( DAI ) and the pathological score of colonic tissues were assessed by routine pathological sections . The expression of IFN - 緯 mRNA and TNF - 偽 mRNA in the distal colon of each group were determined by RT - PCR . The changes of IFN - 緯 and TNF - 偽 in serum of each group were determined by ELISA .
Results ( 1 ) Compared with control group DAI ( 0.29 鹵 0.48 ) and hps ( 0.16 鹵 0.32 ) , DAI ( 6.21 鹵 1.25 ) and hps ( 7.00 鹵 0.58 ) in model group were significantly higher ( p < 0.05 ) .
Compared with model group , DAI ( 4.58 鹵 2.36 ) and HPs ( 4.35 鹵 0.76 ) decreased in group C ( p < 0.05 ) .
The levels of IFN - 緯 and TNF - 偽 in the serum of the model group were significantly higher than those in the control group ( 2.58 鹵 0 . 24 , 0 . 21 鹵 0 . 13 ) ( P < 0 . 05 ) . The levels of IFN - 緯 and TNF - 偽 in the serum of the model group were significantly higher than those in the control group ( 2.58 鹵 0 . 24 , 0 . 21 鹵 0 . 15 ) , and the levels of IFN - 緯 and TNF - 偽 in the serum of the model group were significantly lower than those in the control group ( P < 0 . 05 ) .
Conclusion ( 1 ) The general symptoms of UC mice with anti - CD40 antibody intervention group can be improved obviously , and the degree of colonic inflammation is obviously reduced .
( 2 ) There was a significant decrease in IFN - 緯 mRNA and TNF - 偽 mRNA in the distal colon of UC mice in group D of anti - CD40 antibody , suggesting that pro - inflammatory cytokines might play an important role in the pathogenesis of UC .
( 3 ) The levels of IFN - 緯 and TNF - 偽 in serum of UC mice with anti - CD40 antibody were significantly decreased .
It is suggested that anti - CD40 monoclonal antibody can down - regulate effector cytokines and reduce UC inflammation .
【學(xué)位授予單位】:蘇州大學(xué)
【學(xué)位級(jí)別】:博士
【學(xué)位授予年份】:2014
【分類號(hào)】:R574.62
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 劉占舉;酒金霞;;CD40輔助信號(hào)誘導(dǎo)對(duì)炎癥性腸病患者淋巴細(xì)胞細(xì)胞因子分泌的影響[J];鄭州大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2006年05期
2 吳昊;曹曙光;徐昌隆;裴繼華;鄭波;;亞甲基四氫葉酸還原酶G1793A基因多態(tài)性與潰瘍性結(jié)腸炎的關(guān)系[J];解放軍醫(yī)學(xué)雜志;2011年11期
3 王小蓮;;潰瘍性結(jié)腸炎大鼠模型研究進(jìn)展[J];山西中醫(yī);2011年03期
4 張志軍;劉懿;王磊;蔣曉蕓;陳堅(jiān);孫旭;鐘良;孫大裕;;TLR4mAb對(duì)急性期潰瘍性結(jié)腸炎小鼠結(jié)腸黏膜中促炎因子TNF-α、IFN-γ、IL-1β的影響[J];復(fù)旦學(xué)報(bào)(醫(yī)學(xué)版);2008年02期
5 宋璐;夏冰;;潰瘍性結(jié)腸炎發(fā)病機(jī)制及其診斷[J];中國(guó)實(shí)用內(nèi)科雜志;2010年11期
6 翁一潔;鄭學(xué)寶;;大鼠內(nèi)因濕熱造模方法研究[J];時(shí)珍國(guó)醫(yī)國(guó)藥;2010年02期
7 王赫;周毅;梁磊;陳艷;;CD40在大鼠炎癥性腸病外周血和結(jié)腸組織中的表達(dá)[J];天津醫(yī)藥;2007年07期
8 胡仁偉,歐陽(yáng)欽,陳代云;右旋葡聚糖硫酸鈉小鼠潰瘍性結(jié)腸炎動(dòng)物模型建立方法探討[J];胃腸病學(xué);2002年06期
9 張艷麗;王承黨;;葡聚糖硫酸鈉結(jié)腸炎模型的制作方法、特點(diǎn)和影響因素[J];胃腸病學(xué);2006年01期
10 Charles N.Bernstein;Michael Fried;J.H.Krabshuis;Henry Cohen;R.Eliakim;Suleiman Fedail;Richard Gearry;K.L.Goh;Saheed Hamid;Aamir Ghafor Khan;A.W.LeMair;Malfertheiner;Qin Ouyang;J.F.Rey;Ajit Sood;Flavio Steinwurz;Ole O.Thomsen;Alan Thomson;Gillian Watermeyer;楊釗斌;楊川華;錢本余;;2010年世界胃腸病學(xué)組織關(guān)于炎癥性腸病診斷和治療的實(shí)踐指南[J];胃腸病學(xué);2010年09期
本文編號(hào):1743449
本文鏈接:http://sikaile.net/yixuelunwen/xiaohjib/1743449.html